Dellinger A - Search Results

1

HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.

Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N; Drug Induced Liver Injury Network (DILIN) investigators. Nicoletti P, et al. Among authors: dellinger a. Am J Gastroenterol. 2024 Jan 1;119(1):200-202. doi: 10.14309/ajg.0000000000002454. Epub 2023 Aug 8. Am J Gastroenterol. 2024. PMID: 37552102

2

Comparative analyses of seven algorithms for copy number variant identification from single nucleotide polymorphism arrays.

Dellinger AE, Saw SM, Goh LK, Seielstad M, Young TL, Li YJ. Dellinger AE, et al. Nucleic Acids Res. 2010 May;38(9):e105. doi: 10.1093/nar/gkq040. Epub 2010 Feb 8. Nucleic Acids Res. 2010. PMID: 20142258 Free PMC article.

3

Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim-Sulfamethoxazole Induced Liver Injury.

Li YJ, Phillips EJ, Dellinger A, Nicoletti P, Schutte R, Li D, Ostrov DA, Fontana RJ, Watkins PB, Stolz A, Daly AK, Aithal GP, Barnhart H, Chalasani N; Drug-induced Liver Injury Network. Li YJ, et al. Among authors: dellinger a. Hepatology. 2021 Jan;73(1):268-281. doi: 10.1002/hep.31258. Hepatology. 2021. PMID: 32270503 Free PMC article.

4

Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.

Chalasani N, Li YJ, Dellinger A, Navarro V, Bonkovsky H, Fontana RJ, Gu J, Barnhart H, Phillips E, Lammert C, Schwantes-An TH, Nicoletti P, Kleiner DE, Hoofnagle JH; Drug Induced Liver Injury Network. Chalasani N, et al. Among authors: dellinger a. J Hepatol. 2023 Feb;78(2):293-300. doi: 10.1016/j.jhep.2022.09.010. Epub 2022 Sep 22. J Hepatol. 2023. PMID: 36152763 Free PMC article.

5

Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.

Nicoletti P, Dellinger A, Li YJ, Barnhart HX, Chalasani N, Fontana RJ, Odin JA, Serrano J, Stolz A, Etheridge AS, Innocenti F, Govaere O, Grove JI, Stephens C, Aithal GP, Andrade RJ, Bjornsson ES, Daly AK, Lucena MI, Watkins PB; Drug-Induced Liver Injury Network (DILIN); International Drug-Induced Liver Injury Consortium (iDILIC); Prospective European Drug-Induced Liver Injury (Pro-Euro DILI) Investigators. Nicoletti P, et al. Among authors: dellinger a. Gastroenterology. 2023 Mar;164(3):454-466. doi: 10.1053/j.gastro.2022.11.036. Epub 2022 Dec 7. Gastroenterology. 2023. PMID: 36496055 Free PMC article.

6

When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network.

Barritt AS 4th, Barnhart H, Gu J, Dellinger A, Rudnick S, Bonkovsky HL; DILIN Investigators. Barritt AS 4th, et al. Among authors: dellinger a. Am J Gastroenterol. 2023 Dec 1;118(12):2301-2304. doi: 10.14309/ajg.0000000000002370. Epub 2023 Jun 14. Am J Gastroenterol. 2023. PMID: 37311048 Free PMC article. Review.

7

Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlations.

Bonkovsky HL, Ghabril M, Nicoletti P, Dellinger A, Fontana RJ, Barnhart H, Gu J, Daly AK, Aithal GP, Phillips EJ, Kleiner DE; US DILIN Investigators. Bonkovsky HL, et al. Among authors: dellinger a. Liver Int. 2024 Jun;44(6):1409-1421. doi: 10.1111/liv.15892. Epub 2024 Mar 7. Liver Int. 2024. PMID: 38451034

8

Drug-Induced Liver Injury in Pregnancy: The U.S. Drug-Induced Liver Injury Network Experience.

Masood U, Venturini N, Nicoletti P, Dellinger A, Kleiner D, Bonkovsky HL, Barnhart H, Vuppalanchi R, Rossi S, Odin JA, Kushner T. Masood U, et al. Among authors: dellinger a. Obstet Gynecol. 2024 Jun 1;143(6):819-823. doi: 10.1097/AOG.0000000000005585. Epub 2024 Apr 16. Obstet Gynecol. 2024. PMID: 38626448

9

Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.

Murphy SK, Yang H, Moylan CA, Pang H, Dellinger A, Abdelmalek MF, Garrett ME, Ashley-Koch A, Suzuki A, Tillmann HL, Hauser MA, Diehl AM. Murphy SK, et al. Among authors: dellinger a. Gastroenterology. 2013 Nov;145(5):1076-87. doi: 10.1053/j.gastro.2013.07.047. Epub 2013 Jul 31. Gastroenterology. 2013. PMID: 23916847 Free PMC article.

10

Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer.

Liu Y, Starr MD, Brady JC, Dellinger A, Pang H, Adams B, Theuer CP, Lee NY, Hurwitz HI, Nixon AB. Liu Y, et al. Among authors: dellinger a. Cancer Med. 2014 Jun;3(3):580-91. doi: 10.1002/cam4.207. Epub 2014 Feb 14. Cancer Med. 2014. PMID: 24574330 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page